Comparative Validation of the S-STS, the ISST-Plus, and the C–SSRS for Assessing the Suicidal Thinking and Behavior FDA 2012 Suicidality Categories.

Objective: This exploratory study examines the concurrent validity for mapping symptoms of suicidal ideation, self-harm, and suicidal behavior as recorded on the InterSePT Scale for Suicidal Thinking- Plus, the Sheehan-Suicidality Tracking Scale (clinician- and patient-rated and reconciled patient/c...

Descripción completa

Detalles Bibliográficos
Publicado en:Innovations in Clinical Neuroscience Vol. 11; no. 9/10; pp. 32 - 47
Autores principales: SHEEHAN, DAVID V., ALPHS, LARRY D., LIAN MAO, QIN LI, MAY, ROBERTA S., BRUER, EMILY H., MCCULLUMSMITH, CHERYL B., GRAY, CHRISTOPHER R., XIAOHUA LI, WILLIAMSON, DAVID J.
Formato: pictorial research tables/charts Journal Article
Publicado: Matrix Medical Communications, LLC Sep/Oct2014
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=100082719&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 100082719
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21588333
        DAD5
      jtl: Innovations in Clinical Neuroscience
      issn: 21588333
      maglogo: N
    pubinfo:
      dt: Sep/Oct2014
      vid: 11
      iid: 9/10
      pid: 33670
      pub: Matrix Medical Communications, LLC
      place: West Chester, Pennsylvania
    artinfo:
      ui:
        100082719
        100082719
        103863078
        100082719
      ppf: 32
      ppct: 15
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Comparative Validation of the S-STS, the ISST-Plus, and the C–SSRS for Assessing the Suicidal Thinking and Behavior FDA 2012 Suicidality Categories.
      aug:
        au:
          SHEEHAN, DAVID V.
          ALPHS, LARRY D.
          LIAN MAO
          QIN LI
          MAY, ROBERTA S.
          BRUER, EMILY H.
          MCCULLUMSMITH, CHERYL B.
          GRAY, CHRISTOPHER R.
          XIAOHUA LI
          WILLIAMSON, DAVID J.
        affil: Distinguished University Health Professor Emeritus, University of South Florida College of Medicine, Tampa, Florida.
      sug:
        subj:
          Suicidal Ideation Diagnosis
          Instrument Validation
          Behavior
          United States Food and Drug Administration
          Suicidal Ideation Classification
          Human
          Comparative Studies
          Exploratory Research
          Scales
          Algorithms
          kappa Statistic
          Confidence Intervals
          ROC Curve
          Descriptive Statistics
          McNemar's Test
          Adolescence
          Adult
          Middle Age
          Male
          Female
          Sensitivity and Specificity
          Predictive Value of Tests
          United States
          Funding Source
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Objective: This exploratory study examines the concurrent validity for mapping symptoms of suicidal ideation, self-harm, and suicidal behavior as recorded on the InterSePT Scale for Suicidal Thinking- Plus, the Sheehan-Suicidality Tracking Scale (clinician- and patient-rated and reconciled patient/clinician versions), and the Columbia–Suicide Severity Rating Scale to the 11 United States Food and Drug Administration- Classification Algorithm of Suicide Assessment (September 2012) categories. Method: Forty subjects with varying degrees of suicidal ideation and behavior severity (from not present to extremely severe) were recruited from inpatient, outpatient, and emergency room settings. Each patient was interviewed using all three scales (InterSePT Scale for Suicidal Thinking-Plus, the Sheehan-Suicidality Tracking Scale, and the Columbia–Suicide Severity Rating Scale) on the same day. The scales were administered in a random sequence by three independent raters who were blind to the ratings on the other scales. Results: The Sheehan-Suicidality Tracking Scale and the InterSePT Scale for Suicidal Thinking-Plus show acceptable agreement with the Columbia–Suicide Severity Rating Scale in detecting the presence or absence of the 2012 Food and Drug Administration-Classification Algorithm of Suicide Assessment categories 1, 5, 6, 10, and 11 (passive ideation; active ideation with method, intent, and plan; completed suicide; preparatory actions; and self-injurious behavior) but not of categories 2, 3, and 4 (3 other active suicidal ideation combination categories) or to 8 and 9 (aborted and interrupted attempt). Despite the significant disagreement between the Columbia–Suicide Severity Rating Scale on the one side and the InterSePT Scale for Suicidal Thinking-Plus and the Sheehan- Suicidality Tracking Scale on the other in the ability to accurately map to the 2012 Food and Drug Administration- Classification Algorithm of Suicide Assessment categories on some items, there was close agreement between the InterSePT Scale for Suicidal Thinking-Plus and the Sheehan- Suicidality Tracking Scale on these categories. Conclusion: The results of this exploratory study invite discussion and debate about the validity of the Columbia–Suicide Severity Rating Scale and its ability to accurately assess key active suicidal ideation categories, since it disagrees so much with the other two standardized scales that agree so closely with each other.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N